Literature DB >> 23839023

Core Needle Percutaneous Transpedicular Vertebral Body Biopsy: A Study of 128 Cases.

Yoichi Kamei1, Jun Nishida, Yoshikuni Mimata, Hideo Shiraishi, Shigeru Ehara, Takashi Satoh, Tadashi Shimamura.   

Abstract

STUDY
DESIGN: We report an accurate technique for percutaneous transpedicular core needle biopsy of vertebral body lesions, and evaluate its effectiveness for histologic diagnosis retrospectively.
OBJECTIVE: The purpose of this study is to evaluate the effectiveness and accuracy of this method retrospectively. SUMMARY OF BACKGROUND DATA: Better knowledge of vertebral pedicle morphometry has led to the development of transpedicular fixation techniques in spinal surgery. After experience with these techniques, we have been performing percutaneous transpedicular vertebral body core needle biopsies (transpedicular biopsy) for histologic diagnosis since 1993.
METHODS: A total of 128 patients who had undergone transpedicular biopsy for T1-L5 vertebral body lesions were evaluated. The biopsies were carried out under local anesthesia, except in children, for whom general anesthesia was used. Biopsy specimens were obtained by passing 8 or 11 G needle biopsy instruments percutaneously through the pedicle into the site of the lesion under C-arm fluoroscopy guidance. Histologic analyses were performed, and the accuracy and effectiveness of this technique were evaluated.
RESULTS: The pathologic evaluations were definitive in 120 patients (93.8%) and not diagnostic in 8. The accuracy of the results differed among the diagnostic categories. Diagnostic accuracy was 78.6% for primary neoplasms and 97.0% for metastatic neoplasms. There was a significant difference in the diagnostic criteria and spinal segment. True positive rate was higher in the thoracic spine (92.2%) than that of lumbar spine (76.6%).
CONCLUSIONS: Transpedicular biopsy is a useful procedure for evaluation of thoracic and lumbar vertebral body lesions.

Entities:  

Mesh:

Year:  2015        PMID: 23839023     DOI: 10.1097/BSD.0b013e31829c077a

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  7 in total

Review 1.  Review article: the current status of CT-guided needle biopsy of the spine.

Authors:  Asif Saifuddin; Valentina Palloni; Hannah du Preez; Syed Ehtasham Junaid
Journal:  Skeletal Radiol       Date:  2020-08-19       Impact factor: 2.199

2.  A comparison of two techniques: Open and percutaneous biopsies of thoracolumbar vertebral body lesions.

Authors:  Furkan Yapici; Yunus Atici; Mehmet Bülent Balioglu; Akif Albayrak; Deniz Kargin; Yunus Emre Akman; Sinan Erdogan; Mehmet Akif Kaygusuz
Journal:  J Craniovertebr Junction Spine       Date:  2015 Jan-Mar

3.  Do routine blood test results help in the diagnosis of spine tumors? A retrospective study of the significance of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios from 503 spine tumor patients.

Authors:  Yan Li; Ben Wang; Siyu Zhou; Liang Jiang; Shaomin Yang; Xiaoguang Liu; Feng Wei; Hua Zhang; Yiyuan Wang; Zhongjun Liu
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

4.  Validity of negative bone biopsy in suspicious bone lesions.

Authors:  Mine B Lange; Lars J Petersen; Michael B Nielsen; Helle D Zacho
Journal:  Acta Radiol Open       Date:  2021-07-27

5.  Clinical application of a modified percutaneous vertebroplasty instrument in vertebral body biopsy in adults.

Authors:  Fubiao Zhou; Ningkui Niu; Qiang Liang; Yueliang Chang; Jiandang Shi; Zili Wang
Journal:  BMC Musculoskelet Disord       Date:  2022-02-19       Impact factor: 2.362

6.  Surgical Site Cytology to Diagnose Spinal Lesions.

Authors:  Leon-Gordian Koepke; Annika Heuer; Martin Stangenberg; Marc Dreimann; Lutz Welker; Carsten Bokemeyer; André Strahl; Anne Marie Asemissen; Lennart Viezens
Journal:  Diagnostics (Basel)       Date:  2022-01-26

7.  C-arm Fluoroscopy-Guided Percutaneous Needle Biopsy for the Diagnosis of Spinal Infection: A Study of 203 Consecutive Patients.

Authors:  Gang Zu; Jun Fei; Genjun Chen; Jitang Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-02       Impact factor: 2.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.